Ma et al. demonstrated a significant upregulation of AFAP1‐AS1 expression in breast cancer and cell lines, with elevated levels of AFAP1‐AS1 being associated with an unfavorable prognosis among breast cancer patients. This evidence concerns the gene AFAP1 and breast carcinoma.